LEP and breast cancer: All of the pro-carcinogenic effects attributed to LEP have been confirmed using inhibition assays inhibiting or blocking it (e.g., RNA interference or monoclonal antibodies) which abolish LEP-induced oncogenic effects and BC cell growth in both in vivo and in vitro models [36,85].